Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • VBL Therapeutics

CTech 24/7

  • Regulatory uncertainty risks pushing Israeli AI startups away from Europe
  • Financial tycoon tried to outwit wife but must pay her $37 million
  • Secondaries go mainstream: The quiet force reshaping liquidity across the startup ecosystem
  • Secondaries go mainstream: The quiet force reshaping liquidity across the startup ecosystem
More stories in CTech

VBL Therapeutics

2 stories about VBL Therapeutics
  • VBL Therapeutics CEO Dror Harats

    VBL Therapeutics Aims to Raise $18.75 Million in Public Offering

    20.11.17|Lilach BaumerThe cancer treatment company announced an offering of 2.5 million shares last week

  • Left to right: NanoCarrier CEO Ichiro Nakatomi and VBL Therapeutics CEO Dror Harats

    Japanese NanoCarrier Partners with Cancer Treatment Company VBL Therapeutics

    07.11.17|Dror ReichThe companies signed an exclusive licensing agreement in Japan for VBL's anti-cancer drug

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive